Search Results - "PELTON, Stephen I"

Refine Results
  1. 1

    The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines by Pelton, Stephen I., M.D

    Published in Journal of adolescent health (01-08-2016)
    “…Abstract Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is associated with high morbidity and mortality. Although IMD incidence is…”
    Get full text
    Journal Article
  2. 2

    Population genomics of post-vaccine changes in pneumococcal epidemiology by Croucher, Nicholas J, Finkelstein, Jonathan A, Pelton, Stephen I, Mitchell, Patrick K, Lee, Grace M, Parkhill, Julian, Bentley, Stephen D, Hanage, William P, Lipsitch, Marc

    Published in Nature genetics (01-06-2013)
    “…Nicholas Croucher and colleagues report whole-genome sequencing of 616 asymptomatically carried Streptococcus pneumoniae , a major cause of pneumonia,…”
    Get full text
    Journal Article
  3. 3

    Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine by Yildirim, Inci, MD, MSc, Shea, Kimberly M., PhD, MPH, Pelton, Stephen I., MD

    “…Universal immunization of infants and toddlers with pneumococcal conjugate vaccines over the last 15 years has dramatically altered the landscape of…”
    Get full text
    Journal Article
  4. 4

    Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US by Pelton, Stephen I, Mould-Quevedo, Joaquin F, Nguyen, Van Hung

    Published in Expert review of vaccines (31-12-2024)
    “…Cell-based quadrivalent influenza vaccines (QIVc) can increase effectiveness against seasonal influenza by avoiding mismatch from egg adaption of vaccine…”
    Get full text
    Journal Article
  5. 5

    Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children by Loughlin, Anita M, Hsu, Katherine, Silverio, Amy L, Marchant, Colin D, Pelton, Stephen I

    Published in The Pediatric infectious disease journal (01-05-2014)
    “…BACKGROUND:The direct impact of 13-valent pneumococcal conjugate vaccine (PCV13) on colonization with unique PCV13 serotypes and the uptake of vaccine…”
    Get full text
    Journal Article
  6. 6

    Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease by Bornheimer, Rebecca, Shea, Kimberly M, Sato, Reiko, Weycker, Derek, Pelton, Stephen I

    Published in PloS one (13-10-2017)
    “…Recent evidence demonstrates increased short-term risk of cardiac complications and respiratory failure among patients with heart failure (HF) and chronic…”
    Get full text
    Journal Article
  7. 7

    Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children by Huang, Susan S, Hinrichsen, Virginia L, Stevenson, Abbie E, Rifas-Shiman, Sheryl L, Kleinman, Ken, Pelton, Stephen I, Lipsitch, Marc, Hanage, William P, Lee, Grace M, Finkelstein, Jonathan A

    Published in Pediatrics (Evanston) (01-07-2009)
    “…The goals were to assess serial changes in Streptococcus pneumoniae serotypes and antibiotic resistance in young children and to evaluate whether risk factors…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease by Yildirim, Inci, Shea, Kimberly M, Little, Brent A, Silverio, Amy L, Pelton, Stephen I

    Published in Pediatrics (Evanston) (01-03-2015)
    “…Children with underlying conditions remain at increased risk for invasive pneumococcal diseases (IPD). This study describes the epidemiology, serotype…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review by Mould-Quevedo, Joaquin F., Pelton, Stephen I., Nguyen, Van Hung

    Published in Vaccines (Basel) (01-10-2023)
    “…Cell-based manufacturing of seasonal influenza vaccines eliminates the risk of egg-adaptation of candidate vaccine viruses, potentially increasing vaccine…”
    Get full text
    Journal Article
  15. 15

    The Impact of Adjuvanted Influenza Vaccine on Disease Severity in the US: A Stochastic Model by Pelton, Stephen I, Mould-Quevedo, Joaquin F, Nguyen, Van Hung

    Published in Vaccines (Basel) (26-09-2023)
    “…Influenza can exacerbate underlying medical conditions. In this study, we modelled the potential impact of an egg-based quadrivalent influenza vaccine (QIVe)…”
    Get full text
    Journal Article
  16. 16

    The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses by Fisman, David, Giglio, Norberto, Levin, Myron J, Nguyen, Van Hung, Pelton, Stephen I, Postma, Maarten, Ruiz-Aragón, Jesús, Urueña, Analia, Mould-Quevedo, Joaquin F

    Published in Human vaccines & immunotherapeutics (31-12-2024)
    “…Seasonal influenza significantly affects both health and economic costs in children and adults. This narrative review summarizes published cost-effectiveness…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience by Mrkvan, Tomas, Pelton, Stephen I, Ruiz-Guiñazú, Javier, Palmu, Arto A, Borys, Dorota

    Published in Expert review of vaccines (02-09-2018)
    “…Pneumococcal diseases (including septicemia, meningitis, pneumonia, and upper respiratory infections) constitute a major public health problem. The World…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age by Marshall, Gary S., Pelton, Stephen I., Robertson, Corwin A., Oster, Philipp

    Published in Human vaccines & immunotherapeutics (30-11-2022)
    “…Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs)…”
    Get full text
    Journal Article